T1	Participants 117 123	adults
T2	Participants 1152 1438	Outpatients with cancer were eligible for the study if they were aged >-18 years and had chronic (duration, >/= 3 months) moderate to severe cancer-related pain (score on 10-cm visual analog scale [VAS], > 3 cm [moderate]; score on a 4-point verbal pain-intensity scale, > 1 [moderate])
T3	Participants 2340 2377	aged 60 to 89 years, and 55% were men
T4	Participants 3313 3375	patients with moderate or severe, chronic, cancer-related pain
